Hemophilia: Comprehensive Review and Modern Perspectives

Read full text Summarise with VIRAT
Cited by: 0
References: 2

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hemophilia.A lifelong battle with blood.A missing piece in the clotting puzzle -factor VIII in hemophilia A, factor IX in hemophilia B. The result?Bleeding that just won't stop when it should.It's inherited, passed quietly down the X chromosome.Mostly men suffer it.Women?They usually carry it, hidden but powerful in their genetics.Globally, hemophilia isn't rare.About one in every ten thousand male births -that's not small.Modern science has changed a lot: better diagnostics, safer therapies, longer lives.But for many around the world, treatment is still a dream.Factor concentrates cost.Access is uneven.Clinically, it's painful.Bleeding into joints, muscles, deep tissues.After a simple injury or even without one.The bleeding tells the story of missing factors.The labs confirm it -a prolonged aPTT, normal PT, and low factor VIII or IX levels.Treatment?Replacement.Plasma-derived or recombinant factor concentrates -that's the heart of it.Prophylaxis saves joints.Recombinant therapy saves lives.Now, we have newer ideas -gene therapy, bispecific antibodies, even nonfactor agents.Maybe, someday, a cure.

Fields of Study & Subjects

Hemophilia Treatment and Research Platelet Disorders and Treatments Blood transfusion and management

Publication details

Journal / source
International Research Journal of Modernization in Engineering Technology and Science
Publication date
23 March 2026
Language
EN